Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 20245

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2024 | Month : November | Volume : 18 | Issue : 11 | Page : ZC58 - ZC63 Full Version

Effectiveness of Two Phytochemicals, P-Coumaric Acid and Quercetin in Reducing the Melanin Content of Pigmented Gingival Tissue: An Ex-vivo Study


Published: November 1, 2024 | DOI: https://doi.org/10.7860/JCDR/2024/73197.20295
Shubhangi Behl, Vishakha Patil, Vidya Dodwad

1. Postgraduate Student, Department of Periodontology, Bharati Vidyapeeth (Deemed to be University), Dental College and Hospital, Pune, Maharashtra, India. 2. Professor, Department of Periodontology, Bharati Vidyapeeth (Deemed to be University), Dental College and Hospital, Pune, Maharashtra, India. 3. Professor and Head, Department of Periodontology, Bharati Vidyapeeth (Deemed to be University), Dental College and Hospital, Pune, Maharashtra, India.

Correspondence Address :
Shubhangi Behl,
301 A, Umang Vasant Utsav Thakur Village, Kandivali East, Mumbai-400101, Maharashtra, India.
E-mail: shubhangibehl@gmail.com

Abstract

Introduction: Pigmented gingiva is an aesthetic concern for many individuals. Various treatment modalities have been developed to address this condition, but each carries certain disadvantages. Recently, the use of herbal products has been considered as a treatment modality, as they are safe and readily available. P-Coumaric Acid (p-CA) and Quercetin are two plant-based chemicals that have shown depigmenting effects on the skin. Given the similar cellular structure of skin and gingiva, the present study aimed to test their depigmenting effects on the gingiva.

Aim: To evaluate the effectiveness of two phytochemicals, p-CA (3 μM) and Quercetin (20 μM), in reducing the melanin content of pigmented gingival tissue.

Materials and Methods: The study was an ex-vivo study conducted in the Department of Periodontology at Bharati Vidyapeeth Deemed to be University Dental College and Hospital, Pune, Maharashtra, India, from January 2024 to April 2024. A total of 10 patients with a Dummet Oral Pigmentation Index (DOPI) score of two were selected for the study. A surgical depigmentation procedure was performed and the excised tissue was divided into three parts. The first part of the excised tissue served as a control group (Group A), while the second and third parts were treated with p-CA (Group B) and Quercetin (Group C), respectively. Histological analysis was conducted using Haematoxylin and Eosin (H&E) staining and immunohistochemical analysis was performed using the Human Melanoma Black 45 (HMB-45) antibody test. The reduction in melanin content was recorded in all three groups and the results obtained were compared using a t-test. Statistical Package for the Social Sciences (SPSS) version 20.0 was used for statistical analysis, with a p-value of ≤0.05 considered statistically significant.

Results: Both p-CA and Quercetin demonstrated a reduction in the level of pigmentation. Comparative analysis indicated that p-CA had a stronger effect than Quercetin.

Conclusion: The p-CA and Quercetin can be considered potential depigmenting agents.

Keywords

Flavonoids, Gingiva, Hyperpigmentation, Immunohistochemistry, Melanocytes

A smile increases one's self-confidence in addition to enhancing one's physical attractiveness. The harmony of a beautiful smile is attributed to a multitude of characteristics, including lip position, tooth position and the morphology of the tooth in relation to the gingiva (1). An appealing smile is also influenced by the condition, colour and shape of the gingival tissue. The colour of the gingiva is determined by the number of pigments such as melanin, melanoid, carotene and oxyhaemoglobin (2).

Melanin is found naturally in the skin, gingiva and the remaining portion of the oral mucous membrane. Melanocytes are a particular type of cell that produce this pigment (3). Tyrosinase is an enzyme that catalyses the formation of melanin in specialised organelles called melanosomes.

Numerous treatment approaches have been developed to address hyperpigmented gingiva, as it appears to be a significant aesthetic concern. Additive techniques, such as free gingival grafting or the use of Acellular Dermal Matrix Allograft (ADMA) and subtractive treatment methods, such as conventional techniques (excision/scalpel or stripping surgical technique) (4), bur abrasion technique (5),(6), are employed to remove the hyperpigmented gingival tissue during the periodontal surgical procedure known as gingival depigmentation. Various advanced procedures, including radiosurgery methods (7), cryosurgery (8), lasers (9),(10) and electrosurgery (11), are also utilised. While these surgical techniques and lasers are commonly used to treat gingival hyperpigmentation, they have certain drawbacks. These operations often come with risks of recurrence, extensive postoperative wounds, discomfort and bleeding.

In order to reduce postoperative complications and recurrence rates, along with alleviating patient apprehensions, alternative treatment options are gaining popularity in recent times and can be explored. Nowadays, there is a growing demand for the use of natural products in the field of cosmetics and more people are willing to opt for them as they have fewer to no side-effects and are non toxic (12). Phytochemicals derived from various plant sources have been tried for hyperpigmented lesions of the skin and have achieved great success (13). Thus, understanding the benefits of natural and botanical extracts provides opportunities to develop new products to address pigmentation problems associated not just with the skin but also with the gingiva.

P-Coumaric acid (p-CA) is a common secondary metabolite found in plants. Coumaric acids are derivatives of cinnamic acid. It is present at significant levels in many fruits such as apples, pears, grapes, oranges, tomatoes and berries; in vegetables (e.g., beans, potatoes and onions); and in cereals (e.g., maize, oats and wheat) (14). Previous literature has shown that p-CA, especially its conjugates, exhibits various bioactivities, including antioxidant, anti-inflammatory, anti-mutagenic, anti-ulcer, anti-platelet and anti-cancer activities, in addition to mitigating atherosclerosis, oxidative cardiac damage, Ultraviolet (UV)-induced damage to ocular tissues, neuronal injury, anxiety, gout and diabetes (14).

The p-CA is also found to be a potent anti-melanogenic agent. Its mechanism of action is attributed to the selective inhibition of the enzyme tyrosinase. Its anti-melanogenic effect has been demonstrated in various studies (15),(16). Another phytochemical, quercetin, is a predominant flavanol-type flavonoid present in vegetables, fruits, beverages and medicinal plants. Consequently, quercetin has been extensively studied for its pharmacological benefits, including anti-inflammatory anti atherosclerotic, antioxidant and anti-cancer effects (17). Quercetin has been found to have skin protective properties related to melanogenesis (18),(19). Thus, like p-CA, quercetin is also a selective inhibitor of the enzyme tyrosinase and consequently reduces melanin synthesis. However, to the authors knowledge, no study has been conducted on pigmented gingival tissues.

Considering the anti-melanogenic properties of these phytochemicals, the present study was planned to assess their effectiveness in reducing the melanin content of pigmented gingival tissue. The study aimed to evaluate the effectiveness of two phytochemicals, p-coumaric acid (3 μM) and quercetin (20 μM), in reducing the melanin content of pigmented gingival tissue and to compare the reduction in pigmentation with that of untreated pigmented gingival tissue.

Material and Methods

The present ex-vivo study was conducted at Bharati Vidyapeeth Deemed to be University, Dental College and Hospital, Pune, Maharashtra, India. The research proposal was approved by the Institutional Ethics Committee (IEC) to carry out the study (Regd. No.: EC/NEW/INST/2021/MH/0029).

Individuals visiting the study Institute were carefully selected based on the following inclusion and exclusion criteria.

Inclusion and Exclusion criteria: Systemically healthy subjects of either gender, aged between 18-45 years, with aesthetic concerns regarding physiologic gingival pigmentation, were included in the study. Subjects who had gingival pigmentation due to any other cause, such as smoking or drug use, or any systemic illnesses, such as diabetes or heart disease, as well as individuals with known allergies, pregnant and lactating females, or patients who were not willing to undergo the surgical depigmentation procedure, were excluded from the study.

All individuals fulfilling the above inclusion and exclusion criteria were explained the purpose and design of the study. Verbal and written informed consent was obtained from all participants willing to take part in the study.

Sample size calculation: The sample size was estimated using OpenEpi software (version 3.04):

• Confidence Interval (CI) 95% (2-sided) - 95%
• Alpha (Type 1 error) - 5%
• Beta (Type 2 error) - 20%
• Power - 80%
• value - 0.96
• Effect size - 20%
• Level of significance (usually 5%)

Based on the above data, a sample size of n=10 was derived. A total of 10 subjects with complaints of pigmented gingiva were selected for the study.

Study Procedure

A precise clinical examination was then carried out on a dental chair under standard lighting conditions, using a mouth mirror, explorer and graduated periodontal probe (University of North Carolina/ UNC-15). Subjects with pigmented gingiva were further assessed for their pigmentation score via visual examination using the Dummet Oral Pigmentation Index (DOPI) (20).

Score:

• 0: No clinical pigmentation (pink-coloured gingiva)
• 1: Mild clinical pigmentation (mild light brown colour)
• 2: Moderate clinical pigmentation (medium brown or mixed pink and brown colour)
• 3: Heavy clinical pigmentation (deep brown or bluish-black colour)

Subjects with a DOPI score of 2 were enrolled in the study (Table/Fig 1). Phase I periodontal therapy was carried out for all participants willing to participate in the study. Blood investigations were also advised for all participants before they underwent the surgical depigmentation procedure.

Participants were recalled at regular intervals to assess the status of gingival inflammation. They were scheduled for a depigmentation procedure after the gingival inflammation subsided.

Preparation of phytochemical solutions: The materials used for the preparation of the two phytochemical solutions were obtained commercially. P-Coumaric acid (p-CA) powder was dissolved in 10 mL of Dimethyl Sulfoxide (DMSO) to yield a solution with a concentration of 3 μM. Quercetin powder was dissolved in 10 mL of Dimethyl Sulfoxide (DMSO) to yield a solution with a concentration of 20 μM.

Surgical protocol (21): The surgical procedure was carried out following all universal precautionary guidelines. Subjects were administered local anaesthesia (2% lignocaine with 1:200,000 adrenaline) using a 25-gauge needle via the local infiltration technique. After this, the hyperpigmented gingiva was excised using a scalpel (Table/Fig 2). The excised pigmented gingiva was divided into three parts, each measuring 0.5×0.5 mm.

These three parts were designated as separate groups:

- Group A: Control group
- Group B: P-coumaric acid (p-CA)
- Group C: Quercetin

Group A: The first part of the excised pigmented gingival tissue was used as a control, where none of the phytochemicals were applied. After excision, it was fixed immediately using freshly prepared 10% buffered formalin.

Group B: The second part of the excised pigmented gingival tissue was dipped in 1 mL of 3 μM p-CA for a period of 15 minutes (Table/Fig 3). After a waiting period of 15 minutes, the tissue was washed with fresh saline and then fixed using 10% buffered formalin.

Group C: The third part of the excised pigmented gingival tissue was dipped in 1 mL of 20 μM Quercetin for a period of 15 minutes (Table/Fig 4). After a waiting period of 15 minutes, the tissues were washed with fresh saline and then fixed using freshly prepared 10% buffered formalin. The tissue samples were then sent for histological analysis.

Tissue preparation for histochemistry: The specimens were dehydrated in ascending grades of ethyl alcohol (95%, 99%, 100%), then cleared in xylene and embedded in paraffin. Sections of 4-5 μm in thickness were obtained and collected on positively charged microscope slides. Tissue sections were deparaffinised using xylene and then rehydrated using distilled water before histological staining and immunolabeling.

Histological staining: Tissue sections from all three groups were stained with H&E stain. They were then examined using a light microscope at 40X magnification, equipped with a digital camera.

Immunohistochemical examination (22): In the study, the immunohistochemical examination was carried out using a “polyclonal anti-Human Melanoma Black 45 (anti-HMB-45)” antibody.

The tissue sections were incubated in Phosphate Buffered Saline (PBS) for 10 minutes at 37°C. After two washes with PBS, the unmasking of the antigens was carried out. The antigen (melanocyte) was unmasked by boiling the tissue section in a citrate buffer (pH 6.0) using a microwave oven for three cycles of five minutes each, with a one-minute break in between the cycles. The sections were incubated with the primary antibodies, specifically polyclonal anti-PBS 45 (anti-HMB-45), overnight at 4°C. The following day, after washing in PBS, the sections were incubated with a secondary universal antibody. The substrate DAB (3,3’-Diaminobenzidine) was applied until the desired brown colour developed (2-10 minutes). Finally, the sections were counter-stained with Mayer’s haematoxylin for 30 seconds to visualise the tissue topography.

The melanocytes containing the melanin granules were visualised at a magnification of 400X. The density and distribution of melanin granules were determined by measuring the density of melanin granules based on the scale provided by Patsakas A et al., (1981) (23).

• Score 0: Absence of melanin granules
• Score 1: Rare and scattered melanin granules
• Score 2: Dense but not aggregated melanin granules
• Score 3: Dense and aggregated melanin granules

The scores of melanin pigmentation in the excised gingival tissue treated with the experimental phytochemicals (Groups B and C) and those of untreated tissue (Group A) were noted for each group.

Statistical Analysis

The data obtained was subjected to statistical analysis. SPSS version 20.0 was used for analysing the data. Descriptive data were presented in tables using numbers and percentages. Intergroup comparisons of the study variables were performed using the t-test and post-hoc Tukey’s test. For the above tests, a p-value ≤0.05 was considered statistically significant.

Results

The slides prepared with H&E staining were observed under 40x magnification. Upon examination, all four layers of the gingival epithelium- namely the stratum basale, stratum spinosum, stratum granulosum and stratum corneum- were identified (Table/Fig 5)a-c. All cell layers exhibited intact cellular structures, with no alterations in cell shape, size, or position across all three groups. The nuclei in all cell layers displayed normal shape, size and positioning in all three groups.

For a detailed assessment of melanocytes and the degree of pigmentation, immunohistochemical analysis was conducted using the HMB-45 antibody. (Table/Fig 6)a-c shows the stained slides for the immunohistochemical assay across all three groups at a magnification of 400X.

The reduction in melanin content scores was compared between untreated tissue and tissue treated with the two phytochemicals. The percentage of samples with varying melanin content scores (HMB-45 antibody immunoreaction) for all three groups: Group-A (Control Group), Group-B (3 μM p-CA) and Group-C (20 μM Quercetin) is illustrated in (Table/Fig 7).

The comparison of the mean melanin content scores for all three groups: Group-A (Control Group), Group-B (3 μM p-CA) and Group-C (20 μM Quercetin) is depicted in (Table/Fig 8). The mean melanin content score for Group-A was 3±0.0, while for Group-B it was 1.3±0.45. There was a statistically significant difference between both groups (p-value <0.05), with Group-A exhibiting a higher score compared to Group-B, indicating that Group-B showed less melanin content than Group-A.

The mean melanin content score for Group-A was 3±0.0 and for Group-C, it was 2.3±0.45. There was a statistically significant difference between both groups (p-value <0.05), with Group-C showing less melanin content compared to Group-A.

The mean melanin content score for Group-B was 1.3±0.45, while for Group-C it was 2.3±0.45. There was a statistically significant difference between both groups (p-value <0.05), with Group-C exhibiting more melanin content compared to Group-B.

The differences in mean melanin content scores among the three groups is shown in (Table/Fig 9). The difference was greatest between Group-A and Group-B (-1.7), followed by Group-A and Group-C (-0.7) and Group-B and Group-C (-1). This indicates that a higher reduction in melanin content was observed with Group-B (p-CA) than with Group-C (Quercetin) when compared to the control samples.

Discussion

The study was conducted to evaluate the depigmenting effect of 3 μM of p-CA and 20 μM of Quercetin on excised pigmented gingival tissue. The reduction in melanin content was compared with untreated tissue and also among the tissues treated with the two phytochemicals using immunohistochemical analysis with the HMB-45 antibody. Both plant chemicals tested showed a reduction in melanin content.

Among the various herbal products, p-CA and quercetin have been found to be effective in treating hyperpigmentation lesions (15),(16),(18),(19). Their anti-melanogenic properties have been attributed to their ability to inhibit the enzyme tyrosinase, which is the rate-limiting enzyme in melanogenesis. p-CA has also been found to downregulate the activity of α-melanocyte-stimulating hormone (24),(25), which further inhibits cellular melanogenesis.

Both p-CA and quercetin exhibit antioxidant properties due to their ability to scavenge free radicals and reduce reactive oxygen species (26). Additionally, quercetin has been shown to protect cells from oxidative damage by increasing intracellular antioxidant levels and reducing lipid peroxidation (27). It has also been found to protect melanocytes against H2O2-induced oxidative damage (28).

Owing to the aforementioned properties, it is confirmed that both p-CA and quercetin are potent inhibitors of melanogenesis and can be effectively employed as depigmenting agents.

Different concentrations of these phytochemicals have been studied (24),(25) for their anti-melanogenic effects. In the present study, a lower concentration of p-CA (3 μM) has been used and found to be effective in reducing melanin content. Similarly, Kim A et al., (2011) also found tyrosinase inhibition at a concentration of 3 μM (29). This concentration has also been found to be effective in reducing melanin content in cell cultures of human epidermal melanocytes (24).

Studies have been conducted to assess cellular toxicity caused by p-CA (24),(30). All these studies showed that, at various concentration ranges for the inhibition of cellular melanogenesis, no significant levels of toxicity were noted. In the present study, microscopic examination also revealed no cellular damage. Therefore, the concentrations that demonstrate melanin inhibition can be safely used without damaging the tissues.

In relation to the phytochemical quercetin, various concentrations have been tested for their inhibition of melanogenesis. Arung ET et al., found that quercetin at a concentration of less than 100 μM is able to inhibit melanin content in B16 melanoma cells (31). However, according to Yang YM et al., who evaluated the effect of quercetin at different concentrations on B16 melanoma cells and normal human epidermal melanocytes (32), quercetin was able to reduce melanin content (tyrosinase activity) in a dose-dependent manner at concentrations above 10 μM. In the concentration range of 5-10 μM, there was an increase in tyrosinase activity, whereas a reduction in activity was observed in the 20-50 μM range. Additionally, a reduction in the activity of Tyrosinase Related Protein-1 (TRP-1) and TRP-2 was noted at 20-50 μM. Based on these findings, a concentration of 20 μM was selected for the present study.

However, Nagata H et al., tested quercetin at concentrations of 1, 5, 10 and 20 μM on normal human epidermal melanocytes and human melanoma cells and found an increase in melanin content and enhanced tyrosinase activity (33). Similar results were demonstrated by Takeyama R et al., (34), where quercetin was tested on a human skin model, Melanoderm, in the concentration range of 10-100 μM. Takekoshi S et al., also demonstrated an increase in tyrosinase activity and a subsequent increase in melanin content in human melanoma cells when treated with quercetin in the range of 1-20 μM (35). These findings indicate that the anti-melanogenic effect of quercetin is dose- and cell-specific.

Even though there are studies (31),(32),(33) that indicate a 20 μM concentration of quercetin leads to an increase in tyrosinase activity and subsequent increase in melanin content, the present study has exhibited a positive reduction in melanin content at the 20 μM concentration of quercetin, based on pair-wise comparison using Tukey’s post-hoc analysis.

Various studies have been carried out regarding the cellular toxicity caused by quercetin. Yang YM et al., demonstrated that quercetin at a concentration above 20 μM exhibited cellular toxicity (32). Similarly, Takekoshi S et al., reported no cellular toxicity below 20 μM (35). However, another study (26) reports cellular toxicity at concentrations above 10 μM. Taking this into consideration, the present study was planned accordingly, wherein light microscopic examination was conducted to rule out any cellular damage prior to immunohistochemical analysis. On light microscopic examination, no cellular damage was noted when tissue samples were treated with quercetin at a concentration of 20 μM in the present study.

From the present study, it can thus be concluded that both phytochemicals can reduce cellular melanin content at the specified concentrations without causing any cellular damage.

Limitation(s)

The study was carried out with certain limitations. Only one particular concentration of both phytochemicals was studied. To gain a better understanding of their effects on melanogenesis, a range of concentrations should be employed. The present study was conducted on mildly pigmented lesions, while heavily pigmented lesions were examined at different concentrations. Higher concentrations need to be tested for their cellular toxicity.

Conclusion

Hence, regarding the properties and derivations from the results of the present study, p-CA and quercetin may be considered potential depigmenting agents that could be further developed for intraoral use to treat gingival pigmentation.

References

1.
McLaren EA, Culp L. Smile analysis: The Photoshop smile design technique. Part I. Spring. 2013;29:94-108.
2.
Ozbayrak S, Dumlu A, Ercalik-Yalcinkaya S. Treatment of melanin-pigmented gingiva and oral mucosa by CO2 laser. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(1):14-15. [crossref][PubMed]
3.
Ibusuki M. The color of gingiva studied by visual color matching. Part II. Kind, location, and personal difference in color of gingiva. Bull Tokyo Med Dent Univ. 1975;22(4):281-92.
4.
Sanjeevini H, Pudakalkatti P, Soumya B, Aarati N. Gingival depigmentation: 2 case reports. World Journal of Medical Pharmaceutical and Biological Sciences. 2012;2(1):01-04.
5.
Alqahtani SM. Management of gingival hyperpigmentation by the surgical abrasion: A case report. International Journal of Medical and Dental Case Reports. 2015;2(1):01-03. [crossref]
6.
Garg K, Srivastava R, Verma P. Gingival depigmentation: Clinical comparison between two techniques. Univers Res J Dent. 2012; 2:123-26. [crossref]
7.
Sumit S, Ramandeep G, Simarpreet S, Gurminder S, Vikas S. Radiosurgery in dentistry a brief review. Ann Dent Res. 2012;2:8-20.
8.
Patil KP, Joshi V, Waghmode V, Kanakdande V. Gingival depigmentation: A split mouth comparative study between scalpel and cryosurgery. Contemp Clin Dent. 2015;6(Suppl 1):S97-S101. [crossref][PubMed]
9.
Sims¸ ek Kaya G, Yapici Yavuz G, Sümbüllü MA, Dayi E. A comparison of diode laser and Er:YAG lasers in the treatment of gingival melanin pigmentation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113(3):293-99. [crossref][PubMed]
10.
Nagati RR, Ragul M, Al Qahtani NA, KS R. Clinical effectiveness of gingival depigmentation using conventional surgical scrapping and diode laser technique: A quasi-experimental study. Global Journal of Health Science. 2017;9(3):296-303. [crossref]
11.
Chatterjee A, Singh N, Malhotra P, Ajmera N. Gingival pigmentation and its treatment modalities. J Dent Sci Oral Rehabil. 2012;8:11-14.
12.
Hwang JH, Lee BM. Inhibitory effects of plant extracts on tyrosinase, L-DOPA oxidation, and melanin synthesis. J Toxicol Environ Health A. 2007;70(5):393-407. [crossref][PubMed]
13.
Zhu W, Gao J. The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders. J Investig Dermatol Symp Proc. 2008;13(1):20-24. [crossref][PubMed]
14.
Pragasam SJ, Venkatesan V, Rasool M. Immunomodulatory and anti-inflammatory effect of p-coumaric acid, a common dietary polyphenol on experimental inflammation in rats. Inflammation. 2013;36(1):169-76. [crossref][PubMed]
15.
An SM, Koh JS, Boo YC. p-coumaric acid not only inhibits human tyrosinase activity in vitro but also melanogenesis in cells exposed to UVB. Phytother Res. 2010;24(8):1175-80. [crossref][PubMed]
16.
Seo YK, Kim SJ, Boo YC, Baek JH, Lee SH, Koh JS. Effects of p-coumaric acid on erythema and pigmentation of human skin exposed to ultraviolet radiation. Clin Exp Dermatol. 2011;36(3):260-66. [crossref][PubMed]
17.
Sun AY, Simonyi A, Sun GY. The “French Paradox” and beyond: Neuroprotective effects of polyphenols. Free Radic Biol Med. 2002;32(4):314-18. [crossref][PubMed]
18.
You L, Cho JY. The regulatory role of Korean ginseng in skin cells. J Ginseng Res. 2021;45(3):363-70. [crossref][PubMed]
19.
Park JM, Cho J-K, Mok JY, Jeon IH, Kim HS, Kang HJ, et al. Protective effect of astragalin and quercetin on ultraviolet (UV)-irradiated damage in HaCaT cells and Balb/c mice. J Korean Soc Appl Biol Chem. 2012;55:443-46. [crossref]
20.
Dummett CO, Gupta OP. Estimating the epidemiology of oral pigmentation. J Natl Med Assoc. 1964;56(5):419-20.
21.
Kathariya R, Pradeep AR. Split mouth de-epithelization techniques for gingival depigmentation: A case series and review of literature. J Indian Soc Periodontol. 2011;15(2):161-68. [crossref][PubMed]
22.
Barrett AW, Raja AM. The immunohistochemical identification of human oral mucosal melanocytes. Arch Oral Biol. 1997;42(1):77-81. [crossref][PubMed]
23.
Patsakas A, Demetriou N, Angelopoulos A. Melanin pigmentation and inflammation in human gingiva. J Periodontol. 1981;52(11):701-04. [crossref][PubMed]
24.
An SM, Lee SI, Choi SW, Moon SW, Boo YC. p-Coumaric acid, a constituent of Sasa quelpaertensis Nakai, inhibits cellular melanogenesis stimulated by alpha-melanocyte stimulating hormone. Br J Dermatol. 2008;159(2):292-99. [crossref][PubMed]
25.
Park SH, Kim DS, Park SH, Shin JW, Youn SW, Park KC. Inhibitory effect of p-coumaric acid by Rhodiola sachalinensis on melanin synthesis in B16F10 cells. Pharmazie. 2008;63(4):290-95.
26.
Kim YJ. Hyperin and quercetin modulate oxidative stress-induced melanogenesis. Biol Pharm Bull. 2012;35:2023-27. [crossref][PubMed]
27.
Zhang YM. Protective effect of quercetin on aroclor 1254-induced oxidative damage in cultured chicken spermatogonial cells. Toxicol Sci. 2005;88(2):545-50. [crossref][PubMed]
28.
Jeong YM, Choi YG, Kim DS, Park SH, Yoon JA, Kwon SB, et al. Cytoprotective effect of green tea extract and quercetin against hydrogen peroxide-induced oxidative stress. Arch Pharm Res. 2005;28(11):1251-56. [crossref][PubMed]
29.
Kim A, Yang Y, Lee MS, Yoo YD, Lee HG, Lim JS. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression. Pigment Cell Melanoma Res. 2008;21(6):653-64. [crossref][PubMed]
30.
Song K, An SM, Kim M, Koh JS, Boo YC. Comparison of the antimelanogenic effects of p-coumaric acid and its methyl ester and their skin permeabilities. J Dermatol Sci. 2011;63(1):17-22. [crossref][PubMed]
31.
Arung ET, Furuta S, Ishikawa H, Kusuma IW, Shimizu K, Kondo R. Anti-melanogenesis properties of quercetin-and its derivative-rich extract from Allium cepa. Food Chemistry. 2011;124(3):1024-28. [crossref]
32.
Yang YM, Son YO, Lee SA, Jeon YM, Lee JC. Quercetin inhibits α-MSH-stimulated melanogenesis in B16F10 melanoma cells. Phytother Res. 2011;25(8):1166-73. [crossref][PubMed]
33.
Nagata H, Takekoshi S, Takeyama R, Homma T, Yoshiyuki Osamura R. Quercetin enhances melanogenesis by increasing the activity and synthesis of tyrosinase in human melanoma cells and in normal human melanocytes. Pigment Cell Res. 2004;17(1):66-73.[crossref][PubMed]
34.
Takeyama R, Takekoshi S, Nagata H, Osamura RY, Kawana S. Quercetin-induced melanogenesis in a reconstituted three-dimensional human epidermal model. J Mol Histol. 2004;35(2):157-65. [crossref][PubMed]
35.
Takekoshi S, Nagata H, Kitatani K. Flavonoids enhance melanogenesis in human melanoma cells. Tokai J Exp Clin Med. 2014;39(3):116-21.

DOI and Others

DOI: 10.7860/JCDR/2024/73197.20295

Date of Submission: Jun 24, 2024
Date of Peer Review: Jul 26, 2024
Date of Acceptance: Sep 11, 2024
Date of Publishing: Nov 01, 2024

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Jun 28, 2024
• Manual Googling: Jul 24, 2024
• iThenticate Software: Sep 10, 2024 (13%)

ETYMOLOGY: Author Origin

EMENDATIONS: 7

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com